国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O17:K52:H18 Deoxyguanosinetriphosphate triphosphohydrolase (dgt) CSB-YP485423EOG
CSB-EP485423EOG
CSB-BP485423EOG
CSB-MP485423EOG
CSB-EP485423EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP485424EOG
CSB-EP485424EOG
CSB-BP485424EOG
CSB-MP485424EOG
CSB-EP485424EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Proline--tRNA ligase (proS) CSB-YP485425EOG
CSB-EP485425EOG
CSB-BP485425EOG
CSB-MP485425EOG
CSB-EP485425EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Sigma factor-binding protein crl (crl) CSB-YP485426EOG
CSB-EP485426EOG
CSB-BP485426EOG
CSB-MP485426EOG
CSB-EP485426EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Cyanate hydratase (cynS) CSB-YP485427EOG
CSB-EP485427EOG
CSB-BP485427EOG
CSB-MP485427EOG
CSB-EP485427EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 4-hydroxy-2-oxovalerate aldolase (mhpE) CSB-YP485428EOG
CSB-EP485428EOG
CSB-BP485428EOG
CSB-MP485428EOG
CSB-EP485428EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Recombination-associated protein rdgC (rdgC) CSB-YP485429EOG
CSB-EP485429EOG
CSB-BP485429EOG
CSB-MP485429EOG
CSB-EP485429EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 1-deoxy-D-xylulose-5-phosphate synthase (dxs) CSB-YP485430EOG
CSB-EP485430EOG
CSB-BP485430EOG
CSB-MP485430EOG
CSB-EP485430EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 HMP-PP phosphatase (cof) CSB-YP485431EOG
CSB-EP485431EOG
CSB-BP485431EOG
CSB-MP485431EOG
CSB-EP485431EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 tRNA 2-selenouridine synthase (selU) CSB-YP485432EOG
CSB-EP485432EOG
CSB-BP485432EOG
CSB-MP485432EOG
CSB-EP485432EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Enterobactin exporter EntS (entS), partial CSB-YP485433EOG
CSB-EP485433EOG
CSB-BP485433EOG
CSB-MP485433EOG
CSB-EP485433EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Octanoyltransferase (lipB) CSB-YP485434EOG
CSB-EP485434EOG
CSB-BP485434EOG
CSB-MP485434EOG
CSB-EP485434EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB CSB-YP485435EOG
CSB-EP485435EOG
CSB-BP485435EOG
CSB-MP485435EOG
CSB-EP485435EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 UPF0271 protein YbgL (ybgL) CSB-YP485436EOG
CSB-EP485436EOG
CSB-BP485436EOG
CSB-MP485436EOG
CSB-EP485436EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 PKHD-type hydroxylase ybiX (ybiX) CSB-YP485437EOG
CSB-EP485437EOG
CSB-BP485437EOG
CSB-MP485437EOG
CSB-EP485437EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 UPF0145 protein ybjQ (ybjQ) CSB-YP485438EOG
CSB-EP485438EOG
CSB-BP485438EOG
CSB-MP485438EOG
CSB-EP485438EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Glucans biosynthesis protein C (mdoC), partial CSB-YP485439EOG
CSB-EP485439EOG
CSB-BP485439EOG
CSB-MP485439EOG
CSB-EP485439EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Multidrug resistance protein MdtH (mdtH), partial CSB-YP485440EOG
CSB-EP485440EOG
CSB-BP485440EOG
CSB-MP485440EOG
CSB-EP485440EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Tyrosine--tRNA ligase (tyrS) CSB-YP485441EOG
CSB-EP485441EOG
CSB-BP485441EOG
CSB-MP485441EOG
CSB-EP485441EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 UPF0181 protein yoaH (yoaH) CSB-YP485442EOG
CSB-EP485442EOG
CSB-BP485442EOG
CSB-MP485442EOG
CSB-EP485442EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>